Impact of Fixed-Dose Combinations of Antiretrovirals on Prevalence Trends of HIV Resistance: A 7 Year Follow-Up Study
نویسندگان
چکیده
Angeles Jaen1*, Elisabeth Buira2, Albert Giménez2, Tomás Pumarola3, Teresa Puig4, Jordi Niubó5, Mariona Xercavins6, Daniel Podzamczer5, Bonaventura Clotet4, Josep Maria Gatell3 and David Dalmau1,7 On Behalf of CHRN Group Study 1Fundació Docència i Recerca Mútua Terrassa, Catalonia, Spain 2Direcció General de Salut Pública, Barcelona, Catalonia Government, Spain 3Hospital Clinic-IDIBAPS de Barcelona, Catalonia, Spain 4IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain 5Hospital Universitari de Bellvitge-IDIBELL, Hospitalet, Catalonia, Spain 6Catlab, Catalonia, Spain 7Hospital Universitari MutuaTerrassa, University of Barcelona, Catalonia, Spain
منابع مشابه
Impact of Covid-19 Pandemic on Some Aspects of HIV Surveillance in North of Iran
Background and purpose: COVID-19 could potentially disrupt routine care management in health systems. One of such problems is associated with HIV surveillance. The aim of this research was to study the effects of COVID-19 pandemic on HIV care indicators. Materials and methods: This retrospective cohort study was performed using data at individual and aggregate levels obtained from center for ...
متن کاملLong Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®
Factor XIII deficiency (FXIIID) is an extremely rare hemorrhagic disorder with a prevalence of 1/3-5 million. Management of disease is performed by fresh frozen plasma (FFP), Cryoprecipitate (CP) or FXIII concentrate (Fibrogammin P®). Our objective was to assess safety and effectiveness of Fibrogammin P® in patients with FXIIID. For this purpose we designed this long-term follow up study on a l...
متن کاملLong Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®
Factor XIII deficiency (FXIIID) is an extremely rare hemorrhagic disorder with a prevalence of 1/3-5 million. Management of disease is performed by fresh frozen plasma (FFP), Cryoprecipitate (CP) or FXIII concentrate (Fibrogammin P®). Our objective was to assess safety and effectiveness of Fibrogammin P® in patients with FXIIID. For this purpose we designed this long-term follow up study on a l...
متن کاملPrevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
BACKGROUND Single-dose nevirapine (NVP) is the main option for the prevention of mother-to-child transmission (PMTCT) of HIV-1 in countries with limited resources. However, the use of single-dose NVP results in HIV-1 viral resistance which could compromise the success of subsequent treatment of mother and child with antiretroviral combinations that include non-nucleosidic-reverse-transcriptase ...
متن کاملImplications of Patent Pools on Innovation Regarding Antiretrovirals§
Patent pools have been promoted as an innovative means of promoting the production of fixed-dose combination antiretroviral medicines (ARVs), which can be particularly appropriate for resource-poor settings. An important question, however, is what are the implications of patent pools on innovation for creating new and improved antiretrovirals. Indeed, given the continuing mutation of HIV and gr...
متن کامل